Avedro expands Riboflavin formulations for use in KXL System
Avedro, a global ophthalmic medical device and pharmaceutical company, has expanded its portfolio of proprietary riboflavin formulations for corneal collagen cross-linking.
Original Article: Avedro expands Riboflavin formulations for use in KXL System
NEXT ARTICLE